| Literature DB >> 35574350 |
Hui Wang1, Ying Miao2, Wenjing Yu1, Gan Zhu1, Tao Wu1, Xuefeng Zhao1, Guangjie Yuan1, Biao Li2, Huiqin Xu2.
Abstract
Objective: We sought to explore the feasibility of shorter acquisition times using two short dynamic scans for a multiparametric PET study and the influence of quantitative performance in shortened dynamic PET.Entities:
Keywords: 18F-FDG; Patlak; dynamic PET; positron emission tomography/computed tomography (PET/CT); whole-body parametric imaging
Year: 2022 PMID: 35574350 PMCID: PMC9097952 DOI: 10.3389/fonc.2022.822708
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Clinical characteristics of the patient population and anatomical locations of the detected lesions.
| Patient No. | Sex | Age (years) | Diagnosis | Detected Lesions |
|---|---|---|---|---|
| 1 | Male | 71 | Pancreatic adenocarcinoma | Pancreas (1), lymph node (1), bone (1) |
| 2 | Female | 73 | Lung carcinoma | Lungs (3), lymph nodes (4), bone (1) |
| 3 | Male | 58 | Hepatocellular carcinoma (postoperative) | Liver (1) |
| 4 | Male | 62 | Esophagus cancer (postoperative) | esophageal stoma (1), lymph nodes (5), pleura (3) |
| 5 | Male | 72 | Lung carcinoma | Lung (1), lymph nodes (3) |
| 6 | Female | 36 | Breast carcinoma (postoperative) | Chest wall (1), bones (2) |
| 7 | Male | 49 | Esophagus cancer | Esophagus (1), lymph nodes (5) |
| 8 | Male | 64 | Lung carcinoma | Lung (1), lymph nodes (5), thyroid (1) |
| 9 | Female | 56 | Pulmonary hamartoma | Lung (1), lymph nodes (4), colon (1) |
| 10 | Female | 55 | Pulmonary nodule | Lungs (2) |
| 11 | Male | 68 | Lung carcinoma | Lungs (3), lymph nodes (14), bone (2) |
| 12 | Female | 71 | Lung carcinoma | Lung (1), pleura (1) |
| 13 | Male | 79 | Lung carcinoma | Lungs (4), lymph nodes (5), paranephros (1) |
| 14 | Male | 54 | Lung carcinoma | Lung (1), lymph nodes (4) |
| 15 | Male | 69 | Lung carcinoma | Lung (1), lymph nodes (8), pleura (3) |
| 16 | Female | 50 | Ovarian cancer | Adnexa area (2), pelvic cavity (1), peritoneum (2), lung (1), lymph nodes (7) |
| 17 | Female | 74 | Lung carcinoma | Lung (1), lymph nodes (12), bone (1), thyroid (1) |
| 18 | Female | 50 | Lung carcinoma | Lung (1), lymph nodes (8), |
| 19 | Male | 56 | Pulmonary nodule | Lung (1) |
| 20 | Female | 61 | Pancreatic adenocarcinoma | Pancreas (1) |
| 21 | Male | 81 | Lymphoma | Pancreas (1), lymph node (3) |
Figure 1Imaging protocols. (A) Standard dynamic whole body Patlak parametric PET imaging (last 7 5min). (B) Two short dynamic whole body Patlak parametric PET imaging (0–6 min + 60–75 min post-injection).
Figure 2The input function TACs. (Left) IDIF was automatically generated from proximal descending aorta using dynamic PET series (0–75 min). (Right) TACs of proximal descending aorta were acquired from 0 to 6 min single bed list-mode PET images and the last three frames (60–75 min) dynamic PET series and were merged into one TAC in comma-separated values (CSV) files. The IDIF was then generated by importing these CSV files.
Figure 3Representative static SUVFDG images, and MRFDG and DVFDG images of standard and two short dynamic reconstruction groups. MRFDG and DVFDG images generated from both groups were found with good quality, and showed no visual distinction between the two reconstruction methods. The patient was diagnosed with pulmonary adenocarcinoma (red arrows). The PET scan revealed FDG uptake in multiple lymph nodes in the mediastinum and hilar(blue arrows). Incidental uptake of FDG in the thyroid gland was shown (yellow arrows).
Figure 4Representative MRFDG and DVFDG images of standard and two short dynamic reconstruction groups. The patient was diagnosed with pancreatic adenocarcinoma (red arrows). Intense focal tumoral uptake of FDG was shown on SUV and MRFDG images, while there was no significant increased uptake on DVFDG image. High physiological FDG uptake of colon was also found in types of images (yellow arrows).
MRFDG, DVFDG, and SUV values of normal organs.
| Brain | Lung | Liver | Spleen | Heart wall | Bone | Muscle | ||
|---|---|---|---|---|---|---|---|---|
| MRFDG-std | Max | 0.23 ± 0.06 | 0.01 ± 0.01 | 0.06 ± 0.02 | 0.06 ± 0.12 | 0.19 ± 0.16 | 0.06 ± 0.02 | 0.02 ± 0.01 |
| Mean | 0.17 ± 0.05 | 0.01 ± 0.00 | 0.04 ± 0.01 | 0.04 ± 0.01 | 0.12 ± 0.11 | 0.04 ± 0.02 | 0.01 ± 0.01 | |
| Peak | 0.19 ± 0.05 | 0.01 ± 0.00 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.15 ± 0.13 | 0.05 ± 0.020 | 0.02 ± 0.01 | |
| MRFDG-tsd | Max | 0.22 ± 0.07 | 0.01 ± 0.01 | 0.06 ± 0.02 | 0.06 ± 0.01 | 0.17 ± 0.15 | 0.06 ± 0.02 | 0.02 ± 0.01 |
| Mean | 0.16 ± 0.55 | 0.01 ± 0.00 | 0.04 ± 0.01 | 0.04 ± 0.01 | 0.12 ± 0.11 | 0.04 ± 0.02 | 0.01 ± 0.00 | |
| Peak | 0.19 ± 0.06 | 0.01 ± 0.00 | 0.05 ± 0.02 | 0.04 ± 0.01 | 0.14 ± 0.12 | 0.05 ± 0.02 | 0.02 ± 0.01 | |
| DVFDG-std | Max | 136.42 ± 60.33 | 11.22 ± 6.22 | 58.92 ± 14.13 | 45.32 ± 10.92 | 95.64 ± 49.36 | 36.52 ± 14.48 | 17.41 ± 8.00 |
| Mean | 59.17 ± 21.62 | 4.14 ± 2.18 | 28.35 ± 6.95 | 21.89 ± 3.97 | 48.83 ± 27.61 | 14.62 ± 6.38 | 6.96 ± 3.21 | |
| Peak | 99.19 ± 40.14 | 7.23 ± 4.16 | 39.45 ± 8.57 | 31.15 ± 6.73 | 62.80 ± 31.15 | 22.30 ± 9.13 | 10.69 ± 4.00 | |
| DVFDG-tsd | Max | 126.50 ± 59.01 | 10.80 ± 5.61 | 56.84 ± 19.28 | 41.65 ± 13.19 | 87.35 ± 49.36 | 34.42 ± 14.26 | 16.25 ± 9.30 |
| Mean | 55.78 ± 24.62 | 4.02 ± 2.01 | 26.88 ± 8.34 | 19.75 ± 6.49 | 45.34 ± 25.56 | 13.60 ± 6.11 | 6.45 ± 3.24 | |
| Peak | 92.11 ± 41.65 | 6.83 ± 3.53 | 37.49 ± 11.53 | 28.93 ± 7.70 | 56.83 ± 28.99 | 20.71 ± 8.39 | 10.03 ± 4.72 | |
| SUV | Max | 9.62 ± 2.22 | 0.63 ± 0.32 | 2.92 ± 0.57 | 2.54 ± 0.46 | 7.63 ± 5.60 | 2.65 ± 1.00 | 0.92 ± 0.22 |
| Mean | 7.35 ± 1.87 | 0.40 ± 0.18 | 2.23 ± 0.39 | 2.01 ± 0.31 | 5.47 ± 4.04 | 1.93 ± 0.86 | 0.63 ± 0.14 | |
| Peak | 8.58 ± 1.89 | 0.54 ± 0.26 | 2.49 ± 0.45 | 2.18 ± 0.33 | 6.29 ± 4.59 | 2.24 ± 0.87 | 0.76 ± 0.16 |
MRFDG: umol/min/ml, DVFDG: %.
Passing–Bablok regression of MRFDG and DVFDG of normal organs between different reconstruction groups.
| Intercept A (CI) | Slope B (CI) | Random differences (CI) | Cusum | Spearman rho (CI); | |
|---|---|---|---|---|---|
| MRFDG-max | 0.000 (0.000–0.000) | 1.000 (1.000–1.000) | 0.011 (-0.021–0.021) |
| 0.980 (0.972–0.986); |
| MRFDG-mean | 0.000 (0.000–0.000) | 1.000 (1.000–1.000) | 0.009 (-0.018–0.018) |
| 0.968 (0.955–0.977); |
| MRFDG-peak | 0.000 (0.000–0.000) | 1.000 (1.000–1.000) | 0.009 (-0.017–0.017) |
| 0.977 (0.968–0.983); |
| DVFDG-max | -0.234 (-1.117–0.620) | 0.938 (0.906–0.978) | 7.631 (-14.958–14.958) |
| 0.973 (0.962–0.980); |
| DVFDG-mean | -0.079 (-0.464–0.157) | 0.936 (0.912–0.967) | 3.909 (-7.661–7.661) |
| 0.979 (0.971–0.985); |
| DVFDG-peak | -0.020 (-0.494–0.431) | 0.929 (0.906–0.962) | 4.591 (-8.998–8.998) |
| 0.980 (0.973–0.986); |
Figure 5Passing–Bablok regression (left column) and Bland–Altman plot (right column) of MRFDG and DVFDG values of normal organs between standard and two short dynamic multiparametric images.
Passing–Bablok regression of MRFDG and DVFDG of lesions between different reconstruction groups.
| Intercept A (CI) | Slope B (CI) | Random differences (CI) | Cusum | Spearman rho (CI); | |
|---|---|---|---|---|---|
| MRFDG-max | 0.002 (0.000–0.006) | 0.969 (0.920–1.000) | 0.015 (-0.030–0.030) |
| 0.982 (0.975–0.987); |
| MRFDG-mean | 1.388E-17 (0.000–0.005) | 1.000 (0.906–1.000) | 0.013 (-0.025–0.025) |
| 0.962 (0.947–0.973); |
| MRFDG-peak | 0.000 (0.000–0.000) | 1.000 (1.000–1.000) | 0.012 (-0.023–0.023) |
| 0.977 (0.968–0.984); |
| DVFDG-max | -1.068 (-3.407–1.190) | 0.933 (0.909–0.970) | 13.478 (-26.417–26.417) |
| 0.982 (0.974–0.987); |
| DVFDG-mean | 0.100 (-0.825–0.962) | 0.914 (0.889–0.935) | 5.027 (-9.852–9.852) |
| 0.976 (0.966–0.983); |
| DVFDG-peak | -0.061 (-1.452–1.072) | 0.920 (0.893–0.946) | 7.849 (-15.384–15.384) |
| 0.977 (0.968–0.984); |
Figure 6Passing–Bablok regression (left column) and Bland–Altman plot (right column) of MRFDG and DVFDG values of lesions between standard and two short dynamic multiparametric images.